XML 136 R90.htm IDEA: XBRL DOCUMENT v3.25.4
Shareholders’ equity (deficiency) - Schedule of Option Activity (Details) - $ / shares
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]    
Options outstanding, beginning balance (in shares) 10,472,033  
Granted (in shares) 0  
Exercised (in shares) 5,559,075  
Forfeited (in shares) 307,414  
Options outstanding, ending balance (in shares) 4,605,544 10,472,033
Exercisable (in shares) 3,372,738  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]    
Options outstanding, Weighted average exercise price per share, beginning balance (in USD per share) $ 4.93  
Granted, Weighted average exercise price per share (in USD per share) 0  
Exercised, Weighted average exercise price per share (in USD per share) 3.61  
Forfeited, Weighted average exercise price per share (in USD per share) 7.62  
Options outstanding, Weighted average exercise price per share, ending balance (in USD per share) 6.35 $ 4.93
Exercisable, Weighted average exercise price per share (in USD per share) $ 5.65  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]    
Options outstanding, Weighted average remaining contractual term 6 years 2 months 4 days 6 years 2 months 23 days
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term 5 years 7 months 9 days